Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s) on March 30, 2023.
The above information is a part of company’s filings submitted to BSE.